HR 9321 · 117th Congress · Health

Independent Drug Value Assessment Act

Introduced 2022-11-16· Sponsored by Rep. Speier, Jackie [D-CA-14]· House

Bill Progress

Introduced
2
Committee
3
House Vote
4
Senate
5
Enacted
Latest: Referred to the Subcommittee on Health.(2022-11-17)

Plain Language Summary

[AI summary unavailable — showing source text] Independent Drug Value Assessment Act This bill requires the Office of the Assistant Secretary for Planning and Evaluation to contract with outside entities to conduct independent value assessments of approved drugs (i.e., economic analysis of the benefits to patients and the health care system).…

Summarized by Claude AI · Non-partisan · For informational purposes only

Cosponsors (2)

2 Democrats